•
Jun 30, 2017

Outlook Therapeutics Q3 2017 Earnings Report

Total Revenue
$303K
Previous year: $495K
-38.7%
EPS
-$4
Previous year: -$35.8
-88.8%
Gross Profit
$0
0
Cash and Equivalents
$140K
Previous year: $13.6M
-99.0%
Free Cash Flow
-$15.7M
Total Assets
$17.1M
Previous year: $33M
-48.1%

Outlook Therapeutics

Outlook Therapeutics